/
GTHP
$0.20-$0.04 (-16.62%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.12 – $0.54
18% from low
Exchange
OTC Link
CS
Borrow rate
0.88%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.38
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $57.0K | $36.0K | $102.0K | $81.0K | $13.0K | $98.0K | $7.0K | $767.0K |
| Cost of revenue | $89.0K | $70.0K | −$41.0K | $61.0K | $81.0K | $62.0K | $5.0K | $196.0K |
| Gross profit | −$32.0K | −$34.0K | $143.0K | $20.0K | −$68.0K | $36.0K | $2.0K | $571.0K |
| Gross margin | -56.1% | -94.4% | 140.2% | 24.7% | -523.1% | 36.7% | 28.6% | 74.4% |
| R&D | $244.0K | $122.0K | $143.0K | $69.0K | $77.0K | $228.0K | $526.0K | $469.0K |
| Operating income | −$1.5M | −$937.0K | −$1.1M | −$2.4M | −$3.3M | −$3.5M | −$2.1M | −$2.4M |
| EBITDA | $2.8M | −$488.0K | $798.0K | −$919.0K | −$3.7M | −$3.1M | −$1.9M | −$2.5M |
| Net income | $1.0M | −$1.9M | −$279.0K | −$2.1M | −$4.3M | −$3.5M | −$2.4M | −$3.2M |
| Net margin | 1782.5% | -5336.1% | -273.5% | -2555.6% | -33392.3% | -3560.2% | -34528.6% | -416.7% |
| EPS (diluted) | 0.01 | -0.58 | -0.04 | -0.18 | -0.15 | -0.07 | -0.05 | -0.04 |
Annual figures · source: Financial Modeling Prep
Peer comparison
GUIDED THERAPEUTCS INC
GUIDED THERAPEUTCS INC
Held by traders on TradeandTell
No one on the platform currently holds GTHP.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GTHP as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2019-03-29 | 1-for-800reverse |
| 2016-11-07 | 1-for-800reverse |
| 2016-02-24 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded GTHP yet.